trimethylolpropane phosphite
Trimethylolpropane phosphite (TMPP) is an organophosphorus compound used as a stabilizer in various applications. It is synthesized by reacting trimethylolpropane with phosphorus trichloride. TMPP acts as an antioxidant, preventing oxidation and degradation of materials. Its effectiveness is attributed to its ability to scavenge free radicals. TMPP is widely studied for its potential applications in various industries, including plastics, polymers, and lubricants. It is particularly important as a stabilizer in polyvinyl chloride (PVC) to improve its long-term performance and prevent discoloration. Research focuses on understanding the mechanism of its stabilization and exploring new applications for TMPP in advanced materials.'
Cross-References
ID Source | ID |
---|---|
PubMed CID | 13210 |
SCHEMBL ID | 267114 |
MeSH ID | M0069450 |
Synonyms (49)
Synonym |
---|
1nd7080zyd , |
unii-1nd7080zyd |
4-aethyl-1-phospha-2,6,7-trioxabicyclo(2.2.2)octan |
4-ethyl-2,7-trioxa-1-phosphabicyclo[2.2.2]octane |
4-aethyl-1-phospha-2,7-trioxabicyclo(2.2.2)octan |
nsc-127561 |
trimethylolpropane phosphite |
trimethylolpropane cyclic phosphite (1:1) |
1, 2-ethyl-2-(hydroxymethyl)-, cyclic phosphite (1:1) |
4-ethyl-1-phospha-2,7-trioxabicyclo[2.2.2]octane |
2,7-trioxa-1-phosphabicyclo[2.2.2]octane, 4-ethyl- |
824-11-3 |
nsc127561 |
1,1-trishydroxymethylpropane bicyclic phosphite |
wln: t66 a b ao eopotj c2 |
4-ethyl-2,6,7-trioxa-1-phosphabicyclo[2.2.2]octane |
1,1,1-trishydroxymethylpropane bicyclic phosphite |
4-aethyl-1-phospha-2,6,7-trioxabicyclo(2.2.2)octan [german] |
einecs 212-523-3 |
1,3-propanediol, 2-ethyl-2-(hydroxymethyl)-, cyclic phosphite (1:1) |
hsdb 6409 |
nsc 127561 |
4-ethyl-1-phospha-2,6,7-trioxabicyclo(2.2.2)octane |
1,3-propanediol, 2-ethyl-2-(hydroxymethyl)-, cyclic phosphite |
2-(hydroxymethyl)-2-ethyl-1,3-propanediol, cyclic phosphite (1:1) |
brn 0906923 |
2,6,7-trioxa-1-phosphabicyclo(2.2.2)octane, 4-ethyl- |
4-ethyl-2,6,7-trioxa-1-phosphabicyclo(2.2.2)octane |
inchi=1/c6h11o3p/c1-2-6-3-7-10(8-4-6)9-5-6/h2-5h2,1h |
T0816 |
4-ethyl-1-phospha-2,6,7-trioxabicyclo[2.2.2]octane |
4-ethyl-2,6,7-trioxa-1-phosphabicyclo[2.2.2]octan |
AKOS006230569 |
etpb |
FT-0626263 |
SCHEMBL267114 |
trimethylolpropane phosphite [hsdb] |
2-ethyl-2-hydroxymethyl-1,3-propanediol cyclic phosphite |
1-ethyl-3,5,8-trioxa-4-phospha(2.2.2)bicyclooctane |
ethriol phosphite |
QRUSNTDXJQBKBI-UHFFFAOYSA-N |
2,6,7-trioxa-1-phosphabicyclo[2.2.2]octane, 4-ethyl- |
mfcd00152500 |
triimethylolpropane phosphite |
1,1,1-trimethylolpropane phosphite |
ethyl bicyclic phosphite |
DTXSID10871809 |
Q7842218 |
D92401 |
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 4 (57.14) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.32
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.32) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |